Tag: FDA Adverse Event Reporting System
Post-Market Surveillance: How the FDA Monitors Generic Drugs After Approval
The FDA monitors generic drugs after approval using real-world data, patient reports, and AI tools to catch safety issues that clinical trials miss. Learn how FAERS, Sentinel, and MedWatch keep millions of users safe.
Read MoreRecent News
